PMC:7652766 / 44279-44599 JSONTXT

{"project":"LitCovid-PD-HP","denotations":[{"id":"T97","span":{"begin":104,"end":119},"obj":"Phenotype"}],"attributes":[{"id":"A97","pred":"hp_id","subj":"T97","obj":"http://purl.obolibrary.org/obo/HP_0033041"}],"text":"Therefore, using hemoperfusion can be an important tool to treat severe COVID-19 patients who developed cytokine storms, as well as other treatments focusing on controlling and reducing hyper inflammation using specific blockers or monoclonal antibodies directed against the mediator or to antagonize its receptor (144)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T216","span":{"begin":0,"end":320},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Therefore, using hemoperfusion can be an important tool to treat severe COVID-19 patients who developed cytokine storms, as well as other treatments focusing on controlling and reducing hyper inflammation using specific blockers or monoclonal antibodies directed against the mediator or to antagonize its receptor (144)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"1729","span":{"begin":287,"end":289},"obj":"Gene"},{"id":"1730","span":{"begin":56,"end":58},"obj":"Gene"},{"id":"1731","span":{"begin":81,"end":89},"obj":"Species"},{"id":"1732","span":{"begin":72,"end":80},"obj":"Disease"},{"id":"1733","span":{"begin":186,"end":204},"obj":"Disease"}],"attributes":[{"id":"A1729","pred":"tao:has_database_id","subj":"1729","obj":"Gene:6999"},{"id":"A1730","pred":"tao:has_database_id","subj":"1730","obj":"Gene:6999"},{"id":"A1731","pred":"tao:has_database_id","subj":"1731","obj":"Tax:9606"},{"id":"A1732","pred":"tao:has_database_id","subj":"1732","obj":"MESH:C000657245"},{"id":"A1733","pred":"tao:has_database_id","subj":"1733","obj":"MESH:D007249"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Therefore, using hemoperfusion can be an important tool to treat severe COVID-19 patients who developed cytokine storms, as well as other treatments focusing on controlling and reducing hyper inflammation using specific blockers or monoclonal antibodies directed against the mediator or to antagonize its receptor (144)."}